Data / Drug companies / Labetalol hydrochloride
Labetalol hydrochloride: 43 companies and 140 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Labetalol hydrochloride is listed in the FDA National Drug Code Directory by 43 companies, with 140 products in commercial distribution. 135 of the products (96.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; injection, and the newest product started marketing on October 19, 2026.
The request: Get every company that lists labetalol hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 43
- Products
- 140
- Generic (ANDA) products
- 135 (96.4%)
- Application numbers
- 20
- Routes
- Oral, Intravenous
- Brand names
- Labetalol HCl in Sodium Chloride, Labetalol HCl in Dextrose, Labetalol HCL
- openFDA record search
- api.fda.gov
Companies that list labetalol hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 13 | tablet, film coated | Generic drugs (ANDA) | August 18, 2021 |
| Bryant Ranch Prepack | 9 | tablet, film coated | Generic drugs (ANDA) | August 18, 2021 |
| Hikma Pharmaceuticals USA Inc. | 8 | injection; injection, solution | New drug applications (NDA) | August 28, 2025 |
| BluePoint Laboratories | 6 | tablet; tablet, film coated | Generic drugs (ANDA) | June 4, 2026 |
| Bryant Ranch Prepack | 6 | tablet, film coated | Generic drugs (ANDA) | November 22, 2019 |
| Cardinal Health 107, LLC | 6 | tablet, film coated; injection, solution | Generic drugs (ANDA) | May 6, 2025 |
| Method Pharmaceuticals, LLC | 6 | tablet, film coated | Generic drugs (ANDA) | July 1, 2025 |
| Advagen Pharma Ltd | 4 | tablet, film coated | Generic drugs (ANDA) | May 20, 2025 |
| Biocon Pharma Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | December 2, 2024 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | May 15, 2026 |
| NorthStar RxLLC | 4 | tablet; injection, solution | Generic drugs (ANDA) | March 19, 2026 |
| American Health Packaging | 3 | tablet, film coated | Generic drugs (ANDA) | July 16, 2019 |
| Baxter Healthcare Corporation | 3 | injection, solution | Generic drugs (ANDA) | January 26, 2021 |
| Bryant Ranch Prepack | 3 | tablet, film coated | Generic drugs (ANDA) | November 22, 2019 |
| Cadila Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | May 29, 2018 |
| Chartwell RX, LLC | 3 | tablet | Generic drugs (ANDA) | February 22, 2020 |
| Epic Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | September 30, 2021 |
| Fosun Pharma USA Inc. | 3 | injection | Generic drugs (ANDA) | March 31, 2021 |
| Golden State Medical Supply, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | June 20, 2018 |
| Innogenix, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 8, 2021 |
| Macleods Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | September 23, 2025 |
| Major Pharmaceuticals | 3 | tablet, film coated | Generic drugs (ANDA) | October 8, 2024 |
| Remedyrepack Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 2, 2024 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 1, 2022 |
| Zydus Lifesciences Limited | 3 | tablet, film coated | Generic drugs (ANDA) | December 5, 2017 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | December 5, 2017 |
| Caplin Steriles Limited | 2 | injection, solution | Generic drugs (ANDA) | February 14, 2025 |
| Coupler LLC | 2 | tablet | Generic drugs (ANDA) | October 19, 2026 |
| Hospira, Inc. | 2 | injection, solution | Generic drugs (ANDA) | August 7, 2023 |
| Mullan Pharmaceutical Inc. | 2 | injection | Generic drugs (ANDA) | December 5, 2025 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet, film coated | Generic drugs (ANDA) | May 27, 2021 |
| Onesource Specialty Pharma Limited | 2 | injection | Generic drugs (ANDA) | February 27, 2026 |
| Redpharm Drug | 2 | tablet, film coated | Generic drugs (ANDA) | August 18, 2021 |
| St. Mary's Medical Park Pharmacy | 2 | tablet, film coated | Generic drugs (ANDA) | March 12, 2025 |
| Amneal Pharmaceuticals LLC | 1 | injection, solution | Generic drugs (ANDA) | October 2, 2025 |
| Armas Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | September 15, 2026 |
| Civica, Inc. | 1 | injection | Generic drugs (ANDA) | November 21, 2019 |
| Gland Pharma Limited | 1 | injection, solution | Generic drugs (ANDA) | April 19, 2012 |
| Northwind Health Company, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | April 25, 2023 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | May 27, 2021 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | May 27, 2021 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | August 3, 1998 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | September 1, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 93 | 66.4% |
| Tablet | 18 | 12.9% |
| Injection | 15 | 10.7% |
| Injection, solution | 14 | 10% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 135 | 96.4% |
| New drug applications (NDA) | 5 | 3.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| beta-Adrenergic Blocker | 140 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.